Processa Pharmaceuticals News - PCSA

Company Name	Stock Ticker Symbol	Market	Type
Processa Pharmaceuticals Inc	PCSA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.02	1.25%	1.62	14:28:52

Open Price	Low Price	High Price	Close Price	Prev Close
1.58	1.56	1.6435		1.60

more quote information »

Recent News

Date	Time	Source	Heading
4/11/2024	08:00	GLOBE	Processa Pharmaceuticals Presents Two Abstracts at the AACR..
3/28/2024	08:15	GLOBE	Processa Pharmaceuticals to Present at the MedInvest Biotech..
3/25/2024	08:15	GLOBE	Processa Pharmaceuticals to Present Data at the American..
2/21/2024	17:25	EDGAR2	Form 8-K - Current report
2/21/2024	08:15	GLOBE	Processa Pharmaceuticals to Present at the 2024 BIO CEO &..
2/14/2024	13:00	GLOBE	Processa Pharmaceuticals to Present at The Winter Wrap-Up..
2/06/2024	08:30	EDGAR2	Form 8-K - Current report
2/06/2024	08:30	GLOBE	Processa Pharmaceuticals Regains Compliance with Nasdaq..
2/01/2024	18:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/01/2024	16:22	GLOBE	Processa Pharmaceuticals Announces Closing of $7.0 Million..
1/31/2024	16:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/30/2024	10:46	EDGAR2	Form 8-K - Current report
1/29/2024	16:15	EDGAR2	Form 424B4 - Prospectus [Rule 424(b)(4)]
1/29/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
1/26/2024	09:04	GLOBE	Processa Pharmaceuticals Announces Pricing of $7.0 Million..
1/25/2024	08:35	EDGAR2	Form 8-K - Current report
1/25/2024	08:30	GLOBE	Processa Pharmaceuticals Announces Successful Completion of..
1/19/2024	08:00	EDGAR2	Form 8-K - Current report
1/19/2024	07:45	GLOBE	Processa Pharmaceuticals Announces Expansion of NGC-Cap..
1/18/2024	08:30	EDGAR2	Form 8-K - Current report
1/18/2024	07:45	GLOBE	Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock..
1/08/2024	16:30	EDGAR2	Form 8-K - Current report
1/02/2024	17:06	GLOBE	Processa Pharmaceuticals to Present at the Biotech Showcase..
12/29/2023	08:55	EDGAR2	Form S-1 - General form for registration of securities under..
12/19/2023	09:00	EDGAR2	Form 8-K - Current report
12/19/2023	09:00	GLOBE	Processa Pharmaceuticals Provides Interim Analysis from..
12/13/2023	09:00	GLOBE	Processa Pharmaceuticals Announces Successful Phase 2..
12/05/2023	17:18	EDGAR2	Form 8-K - Current report
11/30/2023	08:15	GLOBE	Processa Pharmaceuticals to Present at the MedInvest..
11/29/2023	08:15	GLOBE	Processa Pharmaceuticals Issues Letter to Shareholders..
11/16/2023	15:10	EDGAR2	Form 8-K - Current report
11/15/2023	11:30	EDGAR2	Form 8-K - Current report
11/13/2023	16:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/2023	14:45	EDGAR2	Form 8-K - Current report
11/13/2023	13:40	GLOBE	Processa Pharmaceuticals, Inc. Mourns the Sudden Passing of..
11/09/2023	08:15	GLOBE	Processa Pharmaceuticals to Present at the 20th Orphan Drugs..
11/01/2023	08:15	GLOBE	Processa Pharmaceuticals Announces Formation of Oncology..
10/16/2023	09:15	EDGAR2	Form 8-K - Current report
10/13/2023	13:08	GLOBE	Processa Pharmaceuticals to Present at the ThinkEquity..
10/12/2023	18:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/12/2023	18:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/12/2023	18:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/12/2023	17:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/10/2023	17:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/10/2023	17:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/10/2023	16:56	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/10/2023	16:51	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
10/05/2023	10:01	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
10/05/2023	10:00	EDGAR2	Form DEF 14A - Other definitive proxy statements
9/25/2023	16:09	EDGAR2	Form PRE 14A - Other preliminary proxy statements